Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) — Board Meeting | 18 September 2026

18 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

47th AGM approved FY26 financials and appointed Anil Kumar Matai as independent director

🔄 What Changed

Appointment of Anil Kumar Matai as independent director

💡 Investor Takeaway

Shareholders approved key governance changes and financials, signaling confidence in leadership continuity.

Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026 via video conference, electing Manish Gupta as chairperson after Harsha Raghavan's absence, approving audited FY26 financials, declaring a dividend, appointing Anil Kumar Matai as independent director, and ratifying Kirit Mehta & CO LLP's remuneration. The meeting concluded at 4:04 p.m. after reviewing operational performance and answering shareholder queries.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,546.8 CrP/E: 34.5ROE: 16.5%ROCE: 21.7%Div Yield: 1.70%

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"What is the remuneration package for Anil Kumar Matai as independent director?""How does the dividend amount compare to previous years' payouts?""What were the key financial highlights in the FY26 audited statements?"

Ask AI Free →

📊 More JAGSNPHARM filings

🔴 Corporate Action — 30 September 2026Jagsonpal Pharmaceuticals announced the allotment of 1,01,825 equity shares of Rs. 2 each under its ...
Announcement — 25 September 2026Jagsonpal Pharmaceuticals has closed its insider trading window effective October 1, 2026, ahead of ...
🔴 Announcement — 23 September 2026Jagsonpal Pharmaceuticals announced on September 23, 2026, that it has entered into a Business Trans...
🔴 Corporate Action — 23 September 2026Jagsonpal Pharmaceuticals announced on September 23, 2026, its agreement to acquire the Wellness Por...
🟡 Voting Results — 21 September 2026Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026 via video conferencing, with votin...

See all JAGSNPHARM filings →

🔥 Also filed on 18 September 2026

MAHABANKBank of MaharashtraCorporate Action GODREJINDGodrej Industries LtdCorporate Action THEMISMEDThemis Medicare LtdCorporate Action CREDITACCCreditAccess Grameen LtdCorporate Action ARFINArfin India LtdCorporate Action GUJTHEMGujarat Themis Biosyn LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.